Why does Cytodyn believe that LL could be effective in treating neuro-inflammatory disease? Was there some evidence of neurological improvement in patients previously treated for HIV, mTNBC, or mCRC?
“This study is designed to evaluate whether modulation of CCR5 can meaningfully impact neuro-inflammatory processes that are increasingly recognized as central to Alzheimer’s disease,” said Dr. Butler." Again, why?
“While CytoDyn remains focused on developing leronlimab in oncology, and we are especially encouraged by the early readouts from our CLOVER Phase 2 study in patients with mCRC, the collaboration with Weill Cornell Medicine in the SALIENT-AD study represents an opportunity to explore potential patient benefit in an indication that represents a significant unmet need,” said Jacob Lalezari, M.D., chief executive officer, CytoDyn.
Did Weill Cornell Medicine initiate the study or did Cytodyn present it to WCM? Is this reflective of treatment of inflammatory disease in multiple indications, as has been discussed here?
https://investorshangout.com/post/view?id=6297787
On its surface this might appear to be an unnecessary detour, as opposed to the glioblastoma effort. OTOH, is Dr. Jay thinking as broadly as Ohm? He has stated that Cytodyn is an oncology company. Why Alzheimer Disease now? What do you think?
“This study is designed to evaluate whether modulation of CCR5 can meaningfully impact neuro-inflammatory processes that are increasingly recognized as central to Alzheimer’s disease,” said Dr. Butler." Again, why?
“While CytoDyn remains focused on developing leronlimab in oncology, and we are especially encouraged by the early readouts from our CLOVER Phase 2 study in patients with mCRC, the collaboration with Weill Cornell Medicine in the SALIENT-AD study represents an opportunity to explore potential patient benefit in an indication that represents a significant unmet need,” said Jacob Lalezari, M.D., chief executive officer, CytoDyn.
Did Weill Cornell Medicine initiate the study or did Cytodyn present it to WCM? Is this reflective of treatment of inflammatory disease in multiple indications, as has been discussed here?
https://investorshangout.com/post/view?id=6297787
On its surface this might appear to be an unnecessary detour, as opposed to the glioblastoma effort. OTOH, is Dr. Jay thinking as broadly as Ohm? He has stated that Cytodyn is an oncology company. Why Alzheimer Disease now? What do you think?
1
